TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 1 | 0 | 2 | -1 | -12 | -20 | -59 | -18 |
| S | %wins | 100 | 0 | 100 | 100 | 100 | 100 | 83 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/13/24 16:15 | 9/13/24 | BFLY | Butterfly Network, Inc. | DE | Health | OthMd | X-Ray Apparatus & Tubes & Rel | Phanstiel S. Louise | NY | D | S | -118 | 1.96 | 0 | -60 | -17 | 285 | I | |||||||||||||||
8/6/21 17:43 | 8/5/21 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Phanstiel S. Louise | UT | D | S.d | -1,678 | 35.04 | 0 | -48 | -30 | 113 | D | |||||||||||||||
12/9/15 17:34 | 12/8/15 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Phanstiel S. Louise | UT | D | S | -220 | 44.00 | 28 | -5 | -27 | 14 | I | 73 | 26 | 35 | 14 | 5 | 2 | 0 | 4 | 0 | 2 | -1 | -12 | -20 | -59 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |